There isn't much market moving news to report. The EU trials slipped a month or two due to severe weather, but unlike prior trials progressive results were to be replaced by a wait for the full trial's completion.
Commercilaisation deals proved a tougher nut than anticipated - and that's about it.
It's all about patience.